Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma
=========================================================================================================================================================================

* Rahima Jamal
* Réjean Lapointe
* Eftihia Cocolakis
* Paméla Thébault
* Shirin Kazemi
* Jennifer E. Friedmann
* Jeanne Dionne
* Jean-François Cailhier
* Karl Bélanger
* Jean-Pierre Ayoub
* Huy Le
* Caroline Lambert
* Jida El-Hajjar
* Léon C. van Kempen
* Alan Spatz
* Wilson H. Miller, Jr